← Eichor
Condition: Prostate Brachytherapy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Prostate Brachytherapy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Optimizing Prostate Cancer Treatment in Men With Advanced Local Disease
NA · 1 location(s) · British Columbia Cancer Agency · NCT03836196PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostat
Phase 2/Phase 3 · 1 location(s) · Affidea Nu-med Center of Oncological DIagnostics and Therapy · NCT07426055Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer
NA · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT07468903Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
Phase 3 · 57 location(s) · Canadian Cancer Trials Group · NCT06235697Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer
Phase N/A · 1 location(s) · British Columbia Cancer Agency · NCT06200974Salvage HDR for Locally Recurrent Prostate Cancer
NA · 1 location(s) · Aarhus University Hospital · NCT04231006Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy
Phase 1/Phase 2 · 1 location(s) · Washington University School of Medicine · NCT03424850Partial Prostate Salvage High Dose Rate Brachytherapy
NA · 1 location(s) · British Columbia Cancer Agency · NCT032468025500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)
NA · 4 location(s) · British Columbia Cancer Agency · NCT04610372Study Evaluating the Efficacy and the Tolerance of Pelvic-prostatic Hypo-fractionated Radiotherapy Followed by Boost in
NA · 2 location(s) · Centre Georges Francois Leclerc · NCT03417336Ultra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost.
NA · 1 location(s) · CHU de Quebec-Universite Laval · NCT05786742High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma
NA · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT04945642Focal Brachytherapy in Patients With Selected "Low-risk" Prostate Cancer - a Phase-II-trial
Phase 2 · 1 location(s) · University of Erlangen-Nürnberg Medical School · NCT02391051PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate
Phase 2/Phase 3 · 1 location(s) · Affidea Nu-med Center of Oncological DIagnostics and Therapy · NCT07426094Evaluating Tolerability of ePUHRT With Brachytherapy Boost
NA · 1 location(s) · Indiana University · NCT06817668HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
Phase 1/Phase 2 · 1 location(s) · The Methodist Hospital Research Institute · NCT01913106A Trial Evaluating Toxicity of SBRT and LDRB in Localized Prostate Cancer.
NA · 1 location(s) · CHU de Quebec-Universite Laval · NCT06052683High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy
Phase N/A · 1 location(s) · Clinica Universidad de Navarra, Universidad de Navarra · NCT06982469High-Dose-Rate Brachytherapy
NA · 1 location(s) · University Health Network, Toronto · NCT00913939Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy
Phase N/A · 3 location(s) · University of Erlangen-Nürnberg Medical School · NCT07131956SBRT vs. Conventional Fractionation With HDR Boost for Prostate Cancer
NA · 1 location(s) · Dr. Gerard Morton · NCT04861415Erectile Dysfunction in Good Prognosis Prostate Cancer : Comparison Between Brachytherapy and Stereotactic Body Radiothe
NA · 20 location(s) · Center Eugene Marquis · NCT03830788High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer
NA · 1 location(s) · University of Nebraska · NCT05754580Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT
EARLY_Phase 1 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT03861676Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer
Phase 1/Phase 2 · 1 location(s) · The Methodist Hospital Research Institute · NCT07182279In Vivo Dosimetry for Brachytherapy Study
Phase N/A · 1 location(s) · East and North Hertfordshire NHS Trust · NCT06863090Focal Salvage Brachytherapy Study (FocaSaBra)
NA · 1 location(s) · The Greater Poland Cancer Centre · NCT05715502Focal HDR Brachytherapy Boost to Stereotactic Radiotherapy
Phase 2 · 2 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT04100174Two-fraction HDR Monotherapy for Localized Prostate Cancer
NA · 1 location(s) · University of California, San Francisco · NCT05665738PSMA PET-Guided Progression-Directed Radiotherapy for Oligoprogressive Prostate Cancer
Phase N/A · 1 location(s) · Affidea Nu-med Center of Oncological DIagnostics and Therapy · NCT07691697
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.